Clinical Trials Browser

Phase EARLY_PHASE1 × Completed × Thyroid Neoplasms × Clear all

NCT02145143 2025-06-18

Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers With the BRAF Inhibitor Vemurafenib: A Pilot Study

Phase EARLY_PHASE1 Completed

Thyroid Neoplasms, Heterotaxy Syndrome

NCT00718770 2014-01-17

A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression

Phase EARLY_PHASE1 Completed

10 enrolled 5 charts

Aggression, Thyroid Neoplasms